Retinopathy of prematurity: from oxygen management to molecular manipulation | Molecular and Cellular Pediatrics | Full Text
Hot Topics in Retinopathy of Prematurity | Pediatric Annals
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial - The Lancet
Treatment of retinopathy of prematurity (ROP)
Intraocular pressure effect of anti-vascular endothelial growth factor injection for aggressive posterior retinopathy of prematurity | Graefe's Archive for Clinical and Experimental Ophthalmology
The Role of Anti-vascular Endothelial Growth Factor Agents in the Management of Retinopathy of Prematurity - touchOPHTHALMOLOGY
RetinaToday | A New Horizon in ROP: The RAINBOW Study
Retinopathy of Prematurity: A NICU Based Approach | IntechOpen
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Screening and Treatment in Retinopathy of Prematurity (23.10.2015)
Retinopathy of prematurity(ROP) – DR. TRYNAADH
38 Clinical Trials and Management of Severe Retinopathy of Prematurity | Ento Key
RetinaToday | ROP: Epidemiology and Clinical Perspective
Retinopathy of prematurity: from oxygen management to molecular manipulation | Molecular and Cellular Pediatrics | Full Text
Retinopathy of prematurity | PPT
JCM | Free Full-Text | The Long-Term Observation of the Beneficial Effects of Treatment: 0.12 mg Anti-VEGF Monotherapy or Anti-VEGF Combined Therapy and Diode-Laser in Various Stages of Retinopathy of Prematurity—Series of
RetinaToday | Clinical Research—Studies on Anti-VEGFs
38 Clinical Trials and Management of Severe Retinopathy of Prematurity | Ento Key
Table 7 from Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity. | Semantic Scholar
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity | NEJM
JCM | Free Full-Text | Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again
